Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
Baxter
Johnson and Johnson
AstraZeneca

Last Updated: December 7, 2021

Volunteer for clinical trials for radium ra-223 dichloride at ClinicalTrialExchange

DrugPatentWatch Database Preview

Radium ra-223 dichloride - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic drug sources for radium ra-223 dichloride and what is the scope of patent protection?

Radium ra-223 dichloride is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Radium ra-223 dichloride has thirty-four patent family members in twenty-one countries.

One supplier is listed for this compound.

Summary for radium ra-223 dichloride
International Patents:34
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 33
DailyMed Link:radium ra-223 dichloride at DailyMed
Recent Clinical Trials for radium ra-223 dichloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jiangnan UniversityPhase 1/Phase 2
Affiliated Hospital of Jiangnan UniversityPhase 1/Phase 2
BayerPhase 4

See all radium ra-223 dichloride clinical trials

Pharmacology for radium ra-223 dichloride

US Patents and Regulatory Information for radium ra-223 dichloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare XOFIGO radium ra-223 dichloride SOLUTION;INTRAVENOUS 203971-001 May 15, 2013 RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for radium ra-223 dichloride

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1140212 122014000052 Germany ⤷  Try it Free PRODUCT NAME: RADIUM-223-SALZ, INSBESONDERE RADIUM-223-DICHLORID; REGISTRATION NO/DATE: EU/1/13/873 20131113
1140212 2014/033 Ireland ⤷  Try it Free PRODUCT NAME: RADIUM-223 AND SALTS THEREOF; REGISTRATION NO/DATE: EU/1/13/873 20131113
1140212 C01140212/01 Switzerland ⤷  Try it Free PRODUCT NAME: RADIUM RA-223; REGISTRATION NO/DATE: SWISSMEDIC 62732 29.08.2014
1140212 C300666 Netherlands ⤷  Try it Free PRODUCT NAME: RADIUM-223, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/13/873/001 20131113
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Medtronic
Baxter
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.